Plain-English translation of NCT07705035 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This trial is testing a new experimental medication called in people with advanced solid tumors (cancers that have spread or cannot be removed with surgery). The study will first figure out the right dose of the medication that is safe and tolerable, then test that dose in a larger group to confirm it works and is safe.
Currently, many people with advanced solid tumors have limited treatment options, especially certain types like endometrial and ovarian cancers. This trial exists to see if this new medication could offer patients another way to fight their cancer.
You likely qualify if…
You likely don't qualify if…
The trial has two parts: first, researchers will gradually increase the dose of the medication in a group of patients to find the safest and most effective dose. Then, a larger group of patients will receive that recommended dose to confirm it is safe and that it helps fight the cancer. You would visit the study center regularly for check-ups, blood tests, and imaging scans to monitor how you are responding to the treatment.
AI-generated summary from trial data · Aug 2, 2026 · Not medical advice
United States